FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1036-1040 April 14, 1994 Number 15 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

ABSTRACT

Background Previous studies suggest that vascular endothelial function may be impaired in essential hypertension. Although muscarinic agonists dilate blood vessels by releasing an endothelium-derived relaxing factor closely related to nitric oxide, nitroprusside dilates vessels by a mechanism that is independent of the endothelium. The finding of an impaired response to muscarinic agonists but a normal response to nitroprusside in patients with hypertension has suggested that endothelial function is abnormal in hypertension.

Methods We reassessed this issue by measuring forearm blood flow by plethysmography during the infusion of vasodilators into the brachial arteries of 95 subjects: 37 normotensive controls (mean [±SE] arterial blood pressure, 92 ±1 mm Hg) and 58 patients with essential hypertension (mean arterial blood pressure, 121 ±1 mm Hg).

Results In an initial study, vascular responses to the vasodilators carbachol and nitroprusside were similar in normotensive controls (n = 19) and hypertensive patients (n = 17). We wondered whether this might be attributable to the use of previously untreated patients or to the choice of carbachol as the muscarinic agonist. However, we found that the vasodilator responses to nitroprusside, acetylcholine, carbachol, and isoproterenol were also similar in separate groups of normotensive controls (n = 18) and hypertensive subjects, whether the subjects had never been treated for hypertension (n = 24) or had had therapy withheld for two weeks (n = 17). The 95 percent confidence intervals for the difference between the controls and hypertensive patients in the ratio of endothelium-dependent vasodilatation induced by acetylcholine or carbachol to endothelium-independent vasodilatation induced by nitroprusside were -14 to +23 percent for acetylcholine and -13 to +12 percent for carbachol.

Conclusions In contrast to previous studies, our findings suggest that selective impairment of the responsiveness of the forearm vasculature to muscarinic agonists is not universal in patients with essential hypertension. .

Source Information

From the Department of Clinical Pharmacology, United Medical and Dental School of Guy's and St. Thomas's Hospitals, University of London, London.

Address reprint requests to Professor Ritter at the Department of Clinical Pharmacology, UMDS, Medical School Building, Guy's Hospital, London SE1 9RT, United Kingdom.

Full Text of this Article

Related Letters:

Endothelium-Dependent Vasodilatation and Essential Hypertension
Panza J. A., Cockcroft J. R., Chowienczyk P. J., Ritter J. M.
Extract | Full Text  
N Engl J Med 1994; 331:951, Oct 6, 1994. Correspondence

This article has been cited by other articles:

• Sumiyoshi, K., Mokuno, H., Iesaki, T., Shimada, K., Miyazaki, T., Kume, A., Kiyanagi, T., Kuremoto, K., Watanabe, Y., Tada, N., Daida, H. (2008). Deletion of the Fc receptors {gamma} chain preserves endothelial function affected by hypercholesterolaemia in mice fed on a high-fat diet. Cardiovasc Res 0: cvn206v2-8 [Abstract] [Full Text]  
• Gkaliagkousi, E., Ritter, J., Ferro, A. (2007). Platelet-Derived Nitric Oxide Signaling and Regulation. Circ. Res. 101: 654-662 [Abstract] [Full Text]  
• Robinson, S. D., Ludlam, C. A., Boon, N. A., Newby, D. E. (2007). Endothelial Fibrinolytic Capacity Predicts Future Adverse Cardiovascular Events in Patients With Coronary Heart Disease. Arterioscler. Thromb. Vasc. Bio. 27: 1651-1656 [Abstract] [Full Text]  
• Wallace, S. M.L., Yasmin, , McEniery, C. M., Maki-Petaja, K. M., Booth, A. D., Cockcroft, J. R., Wilkinson, I. B. (2007). Isolated Systolic Hypertension Is Characterized by Increased Aortic Stiffness and Endothelial Dysfunction. Hypertension 50: 228-233 [Abstract] [Full Text]  
• Hundley, W. G., Bayram, E., Hamilton, C. A., Hamilton, E. A., Morgan, T. M., Darty, S. N., Stewart, K. P., Link, K. M., Herrington, D. M., Kitzman, D. W. (2007). Leg flow-mediated arterial dilation in elderly patients with heart failure and normal left ventricular ejection fraction. Am. J. Physiol. Heart Circ. Physiol. 292: H1427-H1434 [Abstract] [Full Text]  
• Suessenbacher, A., Frick, M., Alber, H. F, Barbieri, V., Pachinger, O., Weidinger, F. (2006). Association of improvement of brachial artery flow-mediated vasodilation with cardiovascular events. Vasc Med 11: 239-244 [Abstract]  
• James, M. A., Tullett, J., Hemsley, A. G., Shore, A. C. (2006). Effects of Aging and Hypertension on the Microcirculation. Hypertension 47: 968-974 [Abstract] [Full Text]  
• Gokce, N. (2004). L-Arginine and Hypertension. J. Nutr. 134: 2807S-2811S [Abstract] [Full Text]  
• Wilkinson, I. B., Franklin, S. S., Cockcroft, J. R. (2004). Nitric Oxide and the Regulation of Large Artery Stiffness: From Physiology to Pharmacology. Hypertension 44: 112-116 [Full Text]  
• CUZZOCREA, S., MAZZON, E., DUGO, L., DI PAOLA, R., CAPUTI, A. P., SALVEMINI, D. (2004). Superoxide: a key player in hypertension. FASEB J. 18: 94-101 [Abstract] [Full Text]  
• Bild, D. E., Bluemke, D. A., Burke, G. L., Detrano, R., Diez Roux, A. V., Folsom, A. R., Greenland, P., JacobsJr., D. R., Kronmal, R., Liu, K., Nelson, J. C., O'Leary, D., Saad, M. F., Shea, S., Szklo, M., Tracy, R. P. (2002). Multi-Ethnic Study of Atherosclerosis: Objectives and Design. Am J Epidemiol 156: 871-881 [Abstract] [Full Text]  
• Molnar, J., Nijland, M. J. M., Howe, D. C., Nathanielsz, P. W. (2002). Evidence for microvascular dysfunction after prenatal dexamethasone at 0.7, 0.75, and 0.8 gestation in sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283: R561-R567 [Abstract] [Full Text]  
• Hyndman, M. E., Parsons, H. G., Verma, S., Bridge, P. J., Edworthy, S., Jones, C., Lonn, E., Charbonneau, F., Anderson, T. J. (2002). The T-786->C Mutation in Endothelial Nitric Oxide Synthase Is Associated With Hypertension. Hypertension 39: 919-922 [Abstract] [Full Text]  
• Irving, R.J, Walker, B.R, Noon, J.P, Watt, G.C.M, Webb, D.J, Shore, A.C (2002). Microvascular correlates of blood pressure, plasma glucose, and insulin resistance in health. Cardiovasc Res 53: 271-276 [Abstract] [Full Text]  
• Joyner, M. J., Dietz, N. M., Shepherd, J. T. (2001). From Belfast to Mayo and beyond: the use and future of plethysmography to study blood flow in human limbs. J. Appl. Physiol. 91: 2431-2441 [Abstract] [Full Text]  
• Chan, N. N., Colhoun, H. M., Vallance, P. (2001). Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population. J Am Coll Cardiol 38: 1814-1820 [Abstract] [Full Text]  
• Gokce, N., Holbrook, M., Duffy, S. J., Demissie, S., Cupples, L.A., Biegelsen, E., Keaney, J. F. Jr, Loscalzo, J., Vita, J. A. (2001). Effects of Race and Hypertension on Flow-Mediated and Nitroglycerin-Mediated Dilation of the Brachial Artery. Hypertension 38: 1349-1354 [Abstract] [Full Text]  
• Jeerooburkhan, N., Jones, L. C., Bujac, S., Cooper, J. A., Miller, G. J., Vallance, P., Humphries, S. E., Hingorani, A. D. (2001). Genetic and Environmental Determinants of Plasma Nitrogen Oxides and Risk of Ischemic Heart Disease. Hypertension 38: 1054-1061 [Abstract] [Full Text]  
• Bello, E., Caramelo, C., Martell, N., Alcazar, J. M., Gonzalez, J., Lopez, M. D., Ruilope, L. M., Gonzalez, F. R., Rovira, A. M., Gazapo, R., Soldevilla, M. J., Casado, S. (2001). Impairment of Renal Vasodilation With L-Arginine Is Related to More Severe Disease in Untreated Hypertensive Patients. Hypertension 38: 907-912 [Abstract] [Full Text]  
• Toikka, J. O., Laine, H., Ahotupa, M., Haapanen, A., Viikari, J. S. A., Hartiala, J. J., Raitakari, O. T (2000). Increased Arterial Intima-Media Thickness and In Vivo LDL Oxidation in Young Men With Borderline Hypertension. Hypertension 36: 929-933 [Abstract] [Full Text]  
• Cockcroft, J. R., Gazis, A. G., Cross, D. J., Wheatley, A., Dewar, J., Hall, I. P., Noon, J. P. (2000). {beta}2-Adrenoceptor Polymorphism Determines Vascular Reactivity in Humans. Hypertension 36: 371-375 [Abstract] [Full Text]  
• Morris, S. T. W., McMurray, J. J. V., Rodger, R. S. C., Jardine, A. G. (2000). Impaired endothelium-dependent vasodilatation in uraemia. Nephrol Dial Transplant 15: 1194-1200 [Abstract] [Full Text]  
• Schiffrin, E. L., Park, J. B., Intengan, H. D., Touyz, R. M. (2000). Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan. Circulation 101: 1653-1659 [Abstract] [Full Text]  
• Sherman, D. L., Keaney, J. F. Jr, Biegelsen, E. S., Duffy, S. J., Coffman, J. D., Vita, J. A. (2000). Pharmacological Concentrations of Ascorbic Acid Are Required for the Beneficial Effect on Endothelial Vasomotor Function in Hypertension. Hypertension 35: 936-941 [Abstract] [Full Text]  
• Butler, R., Morris, A. D., Belch, J. J. F., Hill, A., Struthers, A. D. (2000). Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension. Hypertension 35: 746-751 [Abstract] [Full Text]  
• Vehkavaara, S., Makimattila, S., Schlenzka, A., Vakkilainen, J., Westerbacka, J., Yki-Jarvinen, H. (2000). Insulin Therapy Improves Endothelial Function in Type 2 Diabetes. Arterioscler. Thromb. Vasc. Bio. 20: 545-550 [Abstract] [Full Text]  
• Khan, F., Litchfield, S. J, Stonebridge, P. A, Belch, J. J. (1999). Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease. Vasc Med 4: 233-238 [Abstract]  
• Welch, W. J., Tojo, A., Lee, J.-U., Kang, D. G., Schnackenberg, C. G., Wilcox, C. S. (1999). Nitric oxide synthase in the JGA of the SHR: expression and role in tubuloglomerular feedback. Am. J. Physiol. Renal Physiol. 277: F130-F138 [Abstract] [Full Text]  
• Sander, M., Chavoshan, B., Victor, R. G. (1999). A Large Blood Pressure–Raising Effect of Nitric Oxide Synthase Inhibition in Humans. Hypertension 33: 937-942 [Abstract] [Full Text]  
• Perticone, F., Ceravolo, R., Maio, R., Ventura, G., Iacopino, S., Cuda, G., Mastroroberto, P., Chello, M., Mattioli, P. L. (1999). Calcium antagonist isradipine improves abnormal endothelium-dependent vasodilation in never treated hypertensive patients. Cardiovasc Res 41: 299-306 [Abstract] [Full Text]  
• Dijkhorst-Oei, L.-T., Beutler, J. J., Stroes, E. S.G., Koomans, H. A., Rabelink, T. J. (1998). Divergent effects of ACE-inhibition and calcium channel blockade on NO-activity in systemic and renal circulation in essential hypertension. Cardiovasc Res 40: 402-409 [Abstract] [Full Text]  
• Radaelli, A., Mircoli, L., Mori, I., Mancia, G., Ferrari, A. U. (1998). Nitric Oxide–Dependent Vasodilation in Young Spontaneously Hypertensive Rats. Hypertension 32: 735-739 [Abstract] [Full Text]  
• Laine, H., Knuuti, M. J., Ruotsalainen, U., Utriainen, T., Oikonen, V., Raitakari, M., Luotolahti, M., Kirvela, O., Vicini, P., Cobelli, C., Nuutila, P., Yki-Jarvinen, H. (1998). Preserved Relative Dispersion but Blunted Stimulation of Mean Flow, Absolute Dispersion, and Blood Volume by Insulin in Skeletal Muscle of Patients With Essential Hypertension. Circulation 97: 2146-2153 [Abstract] [Full Text]  
• Cardillo, C., Panza, J. A (1998). Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension. Vasc Med 3: 138-144 [Abstract]  
• Noon, J. P, Walker, B. R, Hand, M. F, Webb, D. J (1998). Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin. Cardiovasc Res 38: 480-484 [Abstract] [Full Text]  
• Hayakawa, H., Raij, L. (1998). Nitric Oxide Synthase Activity and Renal Injury in Genetic Hypertension. Hypertension 31: 266-270 [Abstract] [Full Text]  
• Scherrer, U., Sartori, C. (1997). Insulin as a Vascular and Sympathoexcitatory Hormone : Implications for Blood Pressure Regulation, Insulin Sensitivity, and Cardiovascular Morbidity. Circulation 96: 4104-4113 [Abstract] [Full Text]  
• Joyner, M. J., Dietz, N. M. (1997). Nitric oxide and vasodilation in human limbs. J. Appl. Physiol. 83: 1785-1796 [Abstract] [Full Text]  
• Jern, S., Wall, U., Bergbrant, A., Selin-Sjogren, L., Jern, C. (1997). Endothelium-Dependent Vasodilation and Tissue-Type Plasminogen Activator Release in Borderline Hypertension. Arterioscler. Thromb. Vasc. Bio. 17: 3376-3383 [Abstract] [Full Text]  
• McIntyre, M., Hamilton, C. A., Rees, D. D., Reid, J. L., Dominiczak, A. F. (1997). Sex Differences in the Abundance of Endothelial Nitric Oxide in a Model of Genetic Hypertension. Hypertension 30: 1517-1524 [Abstract] [Full Text]  
• Node, K., Kitakaze, M., Yoshikawa, H., Kosaka, H., Hori, M. (1997). Reduced Plasma Concentrations of Nitrogen Oxide in Individuals With Essential Hypertension. Hypertension 30: 405-408 [Abstract] [Full Text]  
• Hoyer, J., Kohler, R., Distler, A. (1997). Mechanosensitive Cation Channels in Aortic Endothelium of Normotensive and Hypertensive Rats. Hypertension 30: 112-119 [Abstract] [Full Text]  
• Dawes, M., Chowienczyk, P. J., Ritter, J. M. (1997). Effects of Inhibition of the L-Arginine/Nitric Oxide Pathway on Vasodilation Caused by ß-Adrenergic Agonists in Human Forearm. Circulation 95: 2293-2297 [Abstract] [Full Text]  
• Hayakawa, H., Raij, L. (1997). The Link Among Nitric Oxide Synthase Activity, Endothelial Function, and Aortic and Ventricular Hypertrophy in Hypertension. Hypertension 29: 235-241 [Abstract] [Full Text]  
• Iwatsubo, H., Nagano, M., Sakai, T., Kumamoto, K., Morita, R., Higaki, J., Ogihara, T., Hata, T. (1997). Converting Enzyme Inhibitor Improves Forearm Reactive Hyperemia in Essential Hypertension. Hypertension 29: 286-290 [Abstract] [Full Text]  
• Antony, I., Lerebours, G., Nitenberg, A. (1996). Angiotensin-Converting Enzyme Inhibition Restores Flow-Dependent and Cold Pressor Test–Induced Dilations in Coronary Arteries of Hypertensive Patients. Circulation 94: 3115-3122 [Abstract] [Full Text]  
• Benjamin, N., Vane, J. (1996). Nitric Oxide and Hypertension. Circulation 94: 1197-1198 [Full Text]  
• Taddei, S., Virdis, A., Mattei, P., Ghiadoni, L., Sudano, I., Salvetti, A. (1996). Defective L-Arginine–Nitric Oxide Pathway in Offspring of Essential Hypertensive Patients. Circulation 94: 1298-1303 [Abstract] [Full Text]  
• Campese, V. M., Tawadrous, M., Bigazzi, R., Bianchi, S., Mann, A. S., Oparil, S., Raij, L. (1996). Salt Intake and Plasma Atrial Natriuretic Peptide and Nitric Oxide in Hypertension. Hypertension 28: 335-340 [Abstract] [Full Text]  
• Frielingsdorf, J., Seiler, C., Kaufmann, P., Vassalli, G., Suter, T., Hess, O. M. (1996). Normalization of Abnormal Coronary Vasomotion by Calcium Antagonists in Patients With Hypertension. Circulation 93: 1380-1387 [Abstract] [Full Text]  
• Kelm, M., Preik, M., Hafner, D. J., Strauer, B. E. (1996). Evidence for a Multifactorial Process Involved in the Impaired Flow Response to Nitric Oxide in Hypertensive Patients With Endothelial Dysfunction. Hypertension 27: 346-353 [Abstract] [Full Text]  
• Kawamura, M., Adachi, T., Nakajima, J., Fujiwara, T., Hiramori, K. (1996). Factors That Affect Calorie-Sensitive and Calorie-Insensitive Reduction in Blood Pressure During Short-term Calorie Restriction in Overweight Hypertensive Women. Hypertension 27: 408-413 [Abstract] [Full Text]  
• Weber, R., Stergiopulos, N., Brunner, H. R., Hayoz, D. (1996). Contributions of Vascular Tone and Structure to Elastic Properties of a Medium-Sized Artery. Hypertension 27: 816-822 [Abstract] [Full Text]  
• Grunfeld, S., Hamilton, C. A., Mesaros, S., McClain, S. W., Dominiczak, A. F., Bohr, D. F., Malinski, T. (1995). Role of Superoxide in the Depressed Nitric Oxide Production by the Endothelium of Genetically Hypertensive Rats. Hypertension 26: 854-857 [Abstract] [Full Text]  
• Sowers, J. R., Epstein, M. (1995). Diabetes Mellitus and Associated Hypertension, Vascular Disease, and Nephropathy : An Update. Hypertension 26: 869-879 [Abstract] [Full Text]  
• Mimran, A., Ribstein, J., DuCailar, G. (1995). Contrasting Effect of Antihypertensive Treatment on the Renal Response to L-Arginine. Hypertension 26: 937-941 [Abstract] [Full Text]  
• Taddei, S., Virdis, A., Mattei, P., Natali, A., Ferrannini, E., Salvetti, A. (1995). Effect of Insulin on Acetylcholine-Induced Vasodilation in Normotensive Subjects and Patients With Essential Hypertension. Circulation 92: 2911-2918 [Abstract] [Full Text]  
• Donckier, J., Stoleru, L., Hayashida, W., Van Mechelen, H., Selvais, P., Galanti, L., Clozel, J.-P., Ketelslegers, J.-M., Pouleur, H. (1995). Role of Endogenous Endothelin-1 in Experimental Renal Hypertension in Dogs. Circulation 92: 106-113 [Abstract] [Full Text]  
• Bruning, T. A., Chang, P. C., Hendriks, M. G.C., Vermeij, P., Pfaffendorf, M., van Zwieten, P. A. (1995). In Vivo Characterization of Muscarinic Receptor Subtypes That Mediate Vasodilatation in Patients With Essential Hypertension. Hypertension 26: 70-77 [Abstract] [Full Text]  
• Dominiczak, A. F., Bohr, D. F. (1995). Nitric Oxide and Its Putative Role in Hypertension. Hypertension 25: 1202-1211 [Full Text]  
• Ting, C.-T., Chen, J.-W., Chang, M.-S., Yin, F. C. P. (1995). Arterial Hemodynamics in Human Hypertension : Effects of the Calcium Channel Antagonist Nifedipine. Hypertension 25: 1326-1332 [Abstract] [Full Text]  
• Schiffrin, E. L., Deng, L.-Y. (1995). Comparison of Effects of Angiotensin I– Converting Enzyme Inhibition and ß-Blockade for 2 Years on Function of Small Arteries From Hypertensive Patients. Hypertension 25: 699-703 [Abstract] [Full Text]  
• Higashi, Y., Oshima, T., Ozono, R., Watanabe, M., Matsuura, H., Kajiyama, G. (1995). Effects of L-Arginine Infusion on Renal Hemodynamics in Patients With Mild Essential Hypertension. Hypertension 25: 898-902 [Abstract] [Full Text]  
• Bonnardeaux, A., Nadaud, S., Charru, A., Jeunemaitre, X., Corvol, P., Soubrier, F. (1995). Lack of Evidence for Linkage of the Endothelial Cell Nitric Oxide Synthase Gene to Essential Hypertension. Circulation 91: 96-102 [Abstract] [Full Text]  
• Panza, J. A., Cockcroft, J. R., Chowienczyk, P. J., Ritter, J. M. (1994). Endothelium-Dependent Vasodilatation and Essential Hypertension. NEJM 331: 951-951 [Full Text]  
• Luscher, T. F. (1994). The Endothelium and Cardiovascular Disease -- A Complex Relation. NEJM 330: 1081-1083 [Full Text]